OWLT · Owlet, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q are issued.”View the 10-Q filed May 11, 2026
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-08-11 | Owlet Announces Second Quarter 2026 Financial Results |
| 2026-07-23 | Owlet to Report Second Quarter 2026 Financial Results on August 11, 2026 |
| 2026-06-30 | Owlet Announces New $25 Million Credit Facility with Wells Fargo, Significantly Reducing Borrowing Costs and Enhancing Financial Flexibility |
| 2026-05-26 | Owlet to Participate in Upcoming Investor Conferences |
| 2026-05-11 | Owlet Expands ANZ Product Suite with Launch of Dream Sight™ and Dream Duo™ 3, Bringing the World’s Most Comprehensive Baby Monitoring System to More Families |
| 2026-05-07 | Owlet Announces First Quarter 2026 Financial Results; Updates 2026 Guidance |
| 2026-05-04 | Owlet Gives Moms the Ultimate Mother's Day Gift: More Confidence and Peace of Mind |
| 2026-04-30 | Owlet Announces Equity Inducement Award for Kurt Workman in Connection with Re-Appointment as CEO |
| 2026-04-23 | Owlet to Report First Quarter 2026 Financial Results on May 7, 2026 |
| 2026-04-16 | Owlet Launches New Employer Benefit Program, Empowering Companies to Support Parents with Medical-Grade Infant Health Monitoring |
| 2026-04-07 | Owlet Dream Duo™ 3 Named 'Best for Monitoring Baby's Health' in PARENTS 2026 Best for Baby Awards |
| 2026-04-06 | Owlet Announces CEO Transition; Board Reaffirms Q1 2026 Guidance and Long-Term Growth Opportunity |
| 2026-03-26 | Owlet Joins Babylist to Donate Product to Children's Hospital Los Angeles in Support of Make March Matter Campaign |
| 2026-03-05 |
Owlet Reports Fourth Quarter and Full Year 2025 Results; Initiates 2026 Guidance
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today reports financial results for the fourth quarter and full year ended December 31, 2025. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company’s results and provide a business update today, March 5, 2026, at 4:30 p.m. ET. Q4 2025 Financial Highlights: Q4 Revenue of $26.6 million, up 29.6% from Q4 2024 Q4 Gross Profit of $12.6 million, up $1.7 million from Q4 2024 despite tariff cost impacts; Q4 Gross Margin of 47.6% Q4 Operating Loss of $4.9 million, compared to operating loss of $7.4 million in Q4 2024 Q4 Net Loss of $9.2 million, compared to net loss of $9.1 million in Q4 2024 Q4 Adjusted EBITDA (non-GAAP) of $0.1 million, compared to $0.5 million in Q4 2024 Full Year 2025 Financial Highlights: Record FY 2025 Revenue of $105.7 million, up 35.4% from FY 2024 Record FY 2025 |
| 2026-02-24 |
Owlet® Selects Hannah Cranston Media as Public Relations Agency of Record
Award-Winning Agency to Lead Strategic Communication as Owlet Expands Its Mission to Bring More Wellness Insights and Better Starts to Families Worldwide Owlet, Inc . (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced it has selected Hannah Cranston Media (HCM) as its public relations agency of record (AOR). Following a competitive review, Owlet selected HCM for its expertise in health tech, wellness, and consumer innovation, and its demonstrated ability to position mission-driven brands at the center of cultural and industry conversations. Having monitored more than 2.5 million babies globally across 30+ countries, Owlet is setting the standard for pediatric wellness and sleep. The Company successfully scaled its international footprint, including launching its Dream Sock ® in Australia, New Zealand, and South Africa, and secured approval in India’s Central Drugs Standard Control Organization (CDSCO) ahead of its planned expansion into a |
| 2026-02-19 |
Owlet to Report Fourth Quarter and Full Year 2025 Financial Results on March 5, 2026
Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 211338. A simultaneous webcast may be accessed online at the Events section of Owlet’s Investor Relations website at investors.owletcare.com . A replay will be available on the Investor Relations website shortly after the webcast concludes. About Owlet, Inc. Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric |
| 2026-02-11 |
Owlet Announces Strategic DME Partnership with PromptCare to Expand Distribution of Pediatric Pulse Oximeter, BabySat®
The partnership expands Owlet’s pediatric DME distribution footprint and supports extended commercial activation Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare , a leading national respiratory services and durable medical equipment (DME) provider specializing in adult and pediatric care. The partnership expands Owlet’s clinical and DME footprint across key U.S. regions and supports broader access to the Company’s FDA-cleared, prescription pulse oximeter, BabySat, through established pediatric care pathways. Owlet today announced a new strategic partnership with PromptCare, a leading national respiratory services and durable medical equipment (DME) provider specializing in adult and pediatric care. The partnership expands Owlet’s clinical and DME footprint across key U.S. regions and supports broader access to the Company’s FDA-cleared, prescription pulse oximeter, BabySat, |
| 2026-02-03 |
Owlet® Announces Strategic AI Partnership with webAI to Power the Next Generation of Personalized Infant Health and Sleep Insights
Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a strategic partnership with webAI , a leading private AI platform, to accelerate the development of secure, personalized, and data-driven intelligence across the Owlet product ecosystem. The partnership represents a foundational step in Owlet’s long-term AI strategy, focused on leveraging the Company’s proprietary infant health and sleep data to deliver tailored insights for families while building durable, differentiated platform capabilities over time. By investing in enterprise-grade AI infrastructure, Owlet aims to responsibly unlock the value of its unique, vast infant wellness dataset, enabling increasingly personalized experiences for parents and caregivers. “We view AI as a long-term platform investment that strengthens Owlet’s |
| 2026-01-21 |
Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies
Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends Owlet , Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today released its first annual Baby Sleep Report , a review of sleep data gathered from over the 1.2 million babies monitored by Owlet products in 2025. The global report analyzes nearly 900 million hours of monitored infant sleep from babies across 200 geographic regions, offering new insight into sleep patterns, trends, and development – providing parents with data-informed insights to common sleep concerns, while also helping them better understand the connection between sleep and overall wellness. According to the CDC, approximately 40% of infants aged 4-11 months experience short sleep duration, with insufficient sleep linked to poor physical and mental health, attention and behavior problems, and poor |
Past events
Source: https://investors.owletcare.com/overview/default.aspx